Efavaleukin Alfa Uses, Dosage, Side Effects and more
Efavaleukin Alfa is under investigation in clinical trial NCT03422627 (Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease).
| Attribute | Details |
|---|---|
| Trade Name | Efavaleukin Alfa |
| Generic | Efavaleukin alfa |
| Efavaleukin alfa Other Names | Efavaleukin alfa, Fc il-2 mutein fusion protein (amg-592), Immunoglobulin g1 (fc domain-containing fragment) fusion protein with peptide (synthetic linker) fusion protein with interleukin 2 (synthetic human mutein), dimer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
